DOI resolved by resea
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, r…
Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova, Hyun Cheol Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu
https://resea.org/10.1016/s0140-6736(10)61121-x